Valuation: Mecure Industries PLC

Market Cap 225B 167M 149M 136M 124M 234M 15.79B 240M 1.64B 654M 8.36B 627M 614M 26.38B P/E 2024
23.9x
P/E 2025 40.4x
Enterprise Value 274B 203M 181M 166M 151M 285M 19.22B 292M 1.99B 796M 10.18B 763M 747M 32.12B EV / Sales 2024
1.99x
EV / Sales 2025 3.99x
Free-Float
12.71%
Yield 2024
1.08%
Yield 2025 0.49%
6 months-7.87%
Current year-13.80%
1 week 56.2
Extreme 56.2
56.2
1 month 56.2
Extreme 56.2
56.2
Current year 54.55
Extreme 54.55
104
1 year 24.95
Extreme 24.95
104
3 years 5.73
Extreme 5.73
104
5 years 5.73
Extreme 5.73
104
10 years 5.73
Extreme 5.73
104
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%+83.06% - 167M
-3.76%+5.93%+50.49%+140.35% 1,263B
-1.45%+0.47%+45.73%+79.94% 665B
-2.24%+0.79%+33.51%+103.82% 521B
-1.06%-1.78%+48.37%+65.10% 387B
-2.27%+4.26%+75.22%+42.14% 371B
-0.10%+3.79%+32.16%+60.93% 310B
+0.13%+10.01%+12.08%+36.73% 293B
-3.80%+1.87%+55.13%+70.56% 259B
-3.96%+5.26%+36.24%+105.38% 216B
Average -1.77%+5.03%+47.20%+78.33% 428.56B
Weighted average by Cap. -2.27%+5.96%+45.25%+92.43%

Financials

2024 2025
Net sales 46.03B 34.21M 30.48M 27.88M 25.39M 47.86M 3.23B 49.15M 335M 134M 1.71B 128M 126M 5.4B 77.69B 57.74M 51.45M 47.06M 42.86M 80.79M 5.46B 82.97M 565M 226M 2.89B 217M 212M 9.12B
Net income 2.33B 1.73M 1.54M 1.41M 1.28M 2.42M 164M 2.49M 16.95M 6.78M 86.61M 6.5M 6.36M 273M 6.46B 4.8M 4.28M 3.91M 3.57M 6.72M 454M 6.9M 47.03M 18.81M 240M 18.03M 17.64M 758M
Net Debt 35.77B 26.58M 23.69M 21.67M 19.73M 37.19M 2.51B 38.2M 260M 104M 1.33B 99.78M 97.64M 4.2B 48.85B 36.31M 32.35M 29.59M 26.95M 50.8M 3.43B 52.17M 356M 142M 1.82B 136M 133M 5.73B
Projected Income Statement - Annual - Mecure Industries PLC
Logo Mecure Industries PLC
Mecure Industries Plc is a human therapeutics company. The Company is principally in the business of manufacturing drugs, such as tablets, capsules and syrups in Nigeria under two categories namely pharmaceuticals and nutraceuticals. The Company’s Pharmaceuticals segment comprises of over 41 drugs, such as Ebu 200 and 400 (ibuprofen tablets), Laclox, Lamox (an amoxicillin formulation) and Lampicin (an ampicillin formulation), used in treating different ailments. The Nutraceuticals segment consist of approximately 100 products, including multivitamins and dietary supplements. Its products and services include acute ailment medication, chronic ailment medication, nutraceuticals, multivitamins and a planned expansion into chemotherapy medication. It also offers mobile applications, such as the Smart Pill and Smart Buy applications. These applications serve as online pharmacies that facilitate easy purchase and delivery of Company’s products to retail customers in urban cities.
Employees
195
Date Price Change Volume
05/11/26 NGN 56.20 0.00% 19,423
04/11/26 NGN 56.20 0.00% 34,563
03/11/26 NGN 56.20 0.00% 88,823
02/11/26 NGN 56.20 0.00% 77,810
30/10/26 NGN 56.20 0.00% 149,430
  1. Stock Market
  2. Stocks
  3. MECURE Stock